Annual Accounts Payable
$3.27 M
+$1.04 M+46.63%
31 December 2023
Summary:
Poseida Therapeutics annual accounts payable is currently $3.27 million, with the most recent change of +$1.04 million (+46.63%) on 31 December 2023. During the last 3 years, it has risen by +$2.50 million (+328.18%). PSTX annual accounts payable is now -63.54% below its all-time high of $8.96 million, reached on 31 December 2021.PSTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$5.20 M
+$2.21 M+73.81%
30 September 2024
Summary:
Poseida Therapeutics quarterly accounts payable is currently $5.20 million, with the most recent change of +$2.21 million (+73.81%) on 30 September 2024. Over the past year, it has increased by +$2.65 million (+104.45%). PSTX quarterly accounts payable is now -42.00% below its all-time high of $8.96 million, reached on 31 December 2021.PSTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.6% | +104.5% |
| 3 y3 years | +328.2% | +42.6% |
| 5 y5 years | +14.4% | - |
PSTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.5% | +328.2% | -42.0% | +147.8% |
| 5 y | 5 years | -63.5% | +328.2% | -42.0% | +581.1% |
| alltime | all time | -63.5% | +328.2% | -42.0% | +581.1% |
Poseida Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.20 M(+73.8%) |
| June 2024 | - | $2.99 M(+10.6%) |
| Mar 2024 | - | $2.70 M(-17.2%) |
| Dec 2023 | $3.27 M(+46.6%) | $3.27 M(+28.5%) |
| Sept 2023 | - | $2.54 M(+21.2%) |
| June 2023 | - | $2.10 M(-34.5%) |
| Mar 2023 | - | $3.20 M(+43.6%) |
| Dec 2022 | $2.23 M(-75.1%) | $2.23 M(-35.0%) |
| Sept 2022 | - | $3.43 M(-6.4%) |
| June 2022 | - | $3.66 M(+2.0%) |
| Mar 2022 | - | $3.59 M(-59.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $8.96 M(+1074.4%) | $8.96 M(+145.9%) |
| Sept 2021 | - | $3.64 M(-19.1%) |
| June 2021 | - | $4.51 M(+81.2%) |
| Mar 2021 | - | $2.49 M(+226.0%) |
| Dec 2020 | $763.00 K(-84.5%) | $763.00 K(-39.3%) |
| Sept 2020 | - | $1.26 M(-19.6%) |
| June 2020 | - | $1.56 M(-79.7%) |
| Mar 2020 | - | $7.70 M(+56.3%) |
| Dec 2019 | $4.93 M(+72.6%) | $4.93 M |
| Dec 2018 | $2.86 M(+145.4%) | - |
| Dec 2017 | $1.16 M | - |
FAQ
- What is Poseida Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Poseida Therapeutics?
- What is Poseida Therapeutics annual accounts payable year-on-year change?
- What is Poseida Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly accounts payable year-on-year change?
What is Poseida Therapeutics annual accounts payable?
The current annual accounts payable of PSTX is $3.27 M
What is the all time high annual accounts payable for Poseida Therapeutics?
Poseida Therapeutics all-time high annual accounts payable is $8.96 M
What is Poseida Therapeutics annual accounts payable year-on-year change?
Over the past year, PSTX annual accounts payable has changed by +$1.04 M (+46.63%)
What is Poseida Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PSTX is $5.20 M
What is the all time high quarterly accounts payable for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly accounts payable is $8.96 M
What is Poseida Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PSTX quarterly accounts payable has changed by +$2.65 M (+104.45%)